Showing results (111-120 of 143) with videos related to
Sort By:
Pageof 15
Cell Reports|January 18, 2016
KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid MetabolismErhu Zhao, Jane Ding, Yingfeng Xia, et al.Toxicology Letters|April 22, 2017
Pregnane X receptor regulates the AhR/Cyp1A1 pathway and protects liver cells from benzo-[α]-pyrene-induced DNA damageHongmei Cui, Xinsheng Gu, Jingshu Chen, et al.Cell Reports|October 6, 2016
Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming CellsMengling Liu, Yingfeng Xia, Jane Ding, et al.American Journal of Cancer Research|January 9, 2020
SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancerXiaofeng Jin, Jian Wang, Qian Li, et al.American Journal of Cancer Research|December 7, 2023
Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancerXiaofeng Jin, Jian Wang, Qian Li, et al.American Journal of Cancer Research|May 5, 2021
Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancerXiaofeng Jin, Jian Wang, Qian Li, et al.American Journal of Cancer Research|August 15, 2025
Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancerXiaofeng Jin, Jian Wang, Qian Li, et al.Cell Reports. Medicine|January 10, 2025
Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growthOhuod Hawsawi, Weinan Xue, Tingting Du, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2018
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer CellsXiaosong Yang, You Pan, Zhaojun Qiu, et al.Research Square|May 19, 2023
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activityChandra Bhushan Prasad, Adrian Oo, Zhaojun Qiu, et al.Pageof 15